Kewaunee Scientific Q1 Revenue Jumps 47%

Kewaunee Scientific (KEQU) reported robust Q1 FY2026 results, with revenue surging 46.9% to $71.1 million, adjusted EBITDA up 61.5%, and net profit climbing 41.0%, primarily driven by the Nu Aire acquisition and broad-based growth. The company's order backlog reached $205.0 million, a 28.6% year-over-year increase, signaling strong demand. However, management cautioned that project timing variability and ongoing integration costs are expected to lead to uneven results in upcoming quarters, despite forecasting higher consolidated EBITDA for FY2026.

Analysis

Kewaunee Scientific (KEQU) reported a strong fiscal first quarter for 2026, primarily fueled by the recent acquisition of Nu Aire. Revenue surged 46.9% year-over-year to $71.1 million, with adjusted EBITDA growing at an even faster clip of 61.5%, indicating significant operating leverage and successful initial integration. This top-line growth was broad-based, with the Domestic segment up 53.0% and International sales rising 30.2%. Profitability metrics were equally robust, with gross margins expanding to 29.4% from 25.8% in the prior year and GAAP EPS increasing 40.5% to $1.04. The order backlog remains historically strong at $205.0 million, up 28.6% year-over-year, suggesting a healthy demand pipeline. However, management has adopted a cautious outlook, explicitly flagging the potential for "uneven results" due to project timing variability and uncertain regulatory environments. This caution is underscored by a lack of specific revenue or EPS guidance, a slight sequential decline in the order backlog from the prior quarter's $214.6 million, and a widening pre-tax loss in the Corporate segment due to ongoing integration costs and infrastructure investments.

Key Decisions for Investors

• Investors should weigh the strong Q1 performance and successful Nu Aire contribution against management's explicit warnings of near-term volatility, as the project-based nature of the business could lead to significant quarter-to-quarter fluctuations.
• It is critical to monitor the order backlog for sequential growth trends, as the slight dip this quarter, combined with management's cautious tone, could be an early indicator of moderating demand or project delays.
• Given the lack of formal guidance, focus should be on gross margin sustainability and the trajectory of corporate and integration-related expenses in upcoming quarters to determine if the current high profitability is sustainable or a one-off benefit from the acquisition timing.